Brannan Stephen's most recent trade in Karuna Therapeutics Inc was a trade of 4,900 Common Stock done at an average price of $318.3 . Disclosure was reported to the exchange on March 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 318.33 per share. | 08 Mar 2024 | 4,900 | 42,704 (0%) | 0% | 318.3 | 1,559,817 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 3,209 | 12,837 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. | 08 Mar 2024 | 3,209 | 45,813 (0%) | 0% | 131.6 | 422,433 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 2,500 | 4,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Mar 2024 | 2,500 | 42,604 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,791 | 37,813 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. | 08 Mar 2024 | 1,791 | 47,604 (0%) | 0% | 112.0 | 200,538 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 318.96 per share. | 08 Mar 2024 | 100 | 42,604 (0%) | 0% | 319.0 | 31,896 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 10,306 | 10,306 | - | - | Restricted Stock Units | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. | 08 Feb 2024 | 5,000 | 46,150 (0%) | 0% | 112.0 | 559,850 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,000 | 39,604 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 316.05 per share. | 08 Feb 2024 | 4,182 | 41,968 (0%) | 0% | 316.0 | 1,321,721 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 2,500 | 7,177 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Feb 2024 | 2,500 | 41,150 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.14 per share. | 08 Feb 2024 | 1,046 | 40,104 (0%) | 0% | 317.1 | 331,728 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 316.56 per share. | 08 Feb 2024 | 818 | 41,150 (0%) | 0% | 316.6 | 258,946 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 316.81 per share. | 08 Jan 2024 | 15,000 | 38,650 (0%) | 0% | 316.8 | 4,752,150 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. | 08 Jan 2024 | 9,696 | 53,650 (0%) | 0% | 112.0 | 1,085,661 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2024 | 9,696 | 44,604 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. | 08 Jan 2024 | 5,304 | 43,954 (0%) | 0% | 131.6 | 698,219 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2024 | 5,304 | 16,046 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Jan 2024 | 2,500 | 38,650 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2024 | 2,500 | 9,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. | 08 Dec 2023 | 10,000 | 46,150 (0%) | 0% | 131.6 | 1,316,400 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 10,000 | 21,350 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 202.74 per share. | 08 Dec 2023 | 3,969 | 38,500 (0%) | 0% | 202.7 | 804,675 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Dec 2023 | 2,500 | 36,150 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 2,500 | 12,177 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 203.80 per share. | 08 Dec 2023 | 2,251 | 36,249 (0%) | 0% | 203.8 | 458,754 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 201.73 per share. | 08 Dec 2023 | 2,116 | 42,469 (0%) | 0% | 201.7 | 426,861 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 200.11 per share. | 08 Dec 2023 | 1,565 | 44,585 (0%) | 0% | 200.1 | 313,172 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 204.18 per share. | 08 Dec 2023 | 99 | 36,150 (0%) | 0% | 204.2 | 20,214 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. | 08 Nov 2023 | 5,000 | 38,650 (0%) | 0% | 131.6 | 658,200 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2023 | 5,000 | 31,350 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Nov 2023 | 2,500 | 33,650 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2023 | 2,500 | 14,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 180.08 per share. | 08 Nov 2023 | 2,245 | 33,650 (0%) | 0% | 180.1 | 404,280 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 174.11 per share. | 08 Nov 2023 | 1,281 | 37,369 (0%) | 0% | 174.1 | 223,035 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 178.90 per share. | 08 Nov 2023 | 808 | 35,895 (0%) | 0% | 178.9 | 144,551 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 175.69 per share. | 08 Nov 2023 | 401 | 36,968 (0%) | 0% | 175.7 | 70,452 | Common Stock |
| Karuna Therapeutics Inc | Brannan Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 177.14 per share. | 08 Nov 2023 | 265 | 36,703 (0%) | 0% | 177.1 | 46,942 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. | 08 Aug 2023 | 5,000 | 31,150 (0%) | 0% | 131.6 | 658,200 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 5,000 | 46,350 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 08 Aug 2023 | 2,500 | 26,150 (0%) | 0% | 5.5 | 13,625 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 2,500 | 22,177 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 179.53 per share. | 08 Aug 2023 | 2,395 | 28,755 (0%) | 0% | 179.5 | 429,974 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 180.93 per share. | 08 Aug 2023 | 1,355 | 27,400 (0%) | 0% | 180.9 | 245,160 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 181.50 per share. | 08 Aug 2023 | 1,250 | 26,150 (0%) | 0% | 181.5 | 226,875 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 10 Apr 2023 | 5,000 | 28,650 (0%) | 0% | 9.2 | 46,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 176.88 per share. | 10 Apr 2023 | 5,000 | 23,650 (0%) | 0% | 176.9 | 884,400 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 5,000 | 6,362 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 189.51 per share. | 09 Mar 2023 | 5,000 | 23,650 (0%) | 0% | 189.5 | 947,550 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 5,000 | 24,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 09 Mar 2023 | 5,000 | 28,650 (0%) | 0% | 5.5 | 27,250 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 17,350 | 17,350 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,650 | 23,650 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 09 Feb 2023 | 5,000 | 20,000 (0%) | 0% | 5.5 | 27,250 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 5,000 | 29,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 192.37 per share. | 09 Feb 2023 | 5,000 | 15,000 (0%) | 0% | 192.4 | 961,850 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 3,473 | 0 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 197.52 per share. | 09 Jan 2023 | 3,473 | 15,000 (0%) | 0% | 197.5 | 685,987 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Jan 2023 | 3,473 | 18,473 (0%) | 0% | 7.3 | 25,249 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 197.52 per share. | 09 Jan 2023 | 1,527 | 15,000 (0%) | 0% | 197.5 | 301,613 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,527 | 34,677 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 09 Jan 2023 | 1,527 | 16,527 (0%) | 0% | 5.4 | 8,322 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 200.76 per share. | 09 Dec 2022 | 3,637 | 15,000 (0%) | 0% | 200.8 | 730,164 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 3,637 | 3,473 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Dec 2022 | 3,637 | 18,637 (0%) | 0% | 7.3 | 26,441 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 1,363 | 11,362 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 200.76 per share. | 09 Dec 2022 | 1,363 | 15,000 (0%) | 0% | 200.8 | 273,636 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 09 Dec 2022 | 1,363 | 16,363 (0%) | 0% | 9.2 | 12,540 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 216.00 per share. | 09 Nov 2022 | 5,000 | 15,000 (0%) | 0% | 216 | 1,080,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 5,000 | 12,725 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 09 Nov 2022 | 5,000 | 20,000 (0%) | 0% | 9.2 | 46,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 5,000 | 17,725 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 207.51 per share. | 10 Oct 2022 | 5,000 | 15,000 (0%) | 0% | 207.5 | 1,037,550 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 10 Oct 2022 | 5,000 | 20,000 (0%) | 0% | 9.2 | 46,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 243.46 per share. | 09 Sep 2022 | 5,000 | 15,000 (0%) | 0% | 243.5 | 1,217,300 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Sep 2022 | 5,000 | 20,000 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2022 | 5,000 | 7,110 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 228.05 per share. | 09 Aug 2022 | 12,264 | 15,000 (0%) | 0% | 228.0 | 2,796,805 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 09 Aug 2022 | 12,264 | 27,264 (0%) | 0% | 9.2 | 112,829 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 12,264 | 22,725 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 228.13 per share. | 09 Aug 2022 | 7,033 | 15,000 (0%) | 0% | 228.1 | 1,604,438 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Aug 2022 | 7,033 | 22,033 (0%) | 0% | 7.3 | 51,130 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 7,033 | 12,110 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 5,703 | 19,143 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 228.10 per share. | 09 Aug 2022 | 5,703 | 15,000 (0%) | 0% | 228.1 | 1,300,854 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Aug 2022 | 5,703 | 20,703 (0%) | 0% | 7.3 | 41,461 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2022 | 15,000 | 34,989 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 11 Jul 2022 | 15,000 | 30,000 (0%) | 0% | 9.2 | 138,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 133.29 per share. | 11 Jul 2022 | 15,000 | 15,000 (0%) | 0% | 133.3 | 1,999,350 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 110.90 per share. | 09 Jun 2022 | 5,000 | 15,000 (0%) | 0% | 110.9 | 554,500 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 5,000 | 49,989 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 09 Jun 2022 | 5,000 | 20,000 (0%) | 0% | 9.2 | 46,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 104.10 per share. | 09 May 2022 | 5,000 | 15,000 (0%) | 0% | 104.1 | 520,500 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 5,000 | 54,989 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. | 09 May 2022 | 5,000 | 20,000 (0%) | 0% | 9.2 | 46,000 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 128.45 per share. | 01 Apr 2022 | 7,728 | 15,000 (0%) | 0% | 128.5 | 992,662 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 01 Apr 2022 | 7,728 | 22,728 (0%) | 0% | 7.3 | 56,183 | Common Stock |
| Karuna Therapeutics Inc | Stephen Brannan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 7,728 | 24,846 | - | - | Option (right to buy) |